US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 02:17:19 Source：Earth Essence news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Mark Wahlberg's new action
- Next：Supreme Court declines to hear challenge to Maryland ban on rifles known as assault weapons
Related articles
- NBA playoffs: Edwards leads Wolves to 98
- Continued funding concerns among disabled communities
- Tarata Road gravel fix plan raises ire of small Taranaki community
- Israel approves plan to attack Rafah but keeps truce hopes alive
- DR MARTIN SCURR: How losing your hearing may cause dementia
- Hundreds of bulbs, entire rose bushes stolen from Christchurch park
- Kāinga Ora cans controversial social housing development, saying it is not financially viable
- Truancy: Why it matters, what the law says and what is being done about it
- Kate Hudson hits the stage to debut songs from her new album Glorious at star
- Doctors who visited Gaza speak of 'atrocities', collapsing healthcare
- Revealed: Brit tourist, 19, subjected to sex attack in Majorca 'was gang
- Man accused of Ellerslie murder named
- Opportunities Party leader Raf Manji resigns
- Old commuter carriages blighting Taumarunui scrapped after years of decay
- Arrest Lord Mountbatten's self
- Christchurch Adventure Park to reopen on Friday, 22 March
- 'Not just Māori but all of us'
- Israel approves plan to attack Rafah but keeps truce hopes alive
- Amal Clooney played key role in ICC bid to request arrest warrants for Israeli PM and Hamas leader
- Hundreds of bulbs, entire rose bushes stolen from Christchurch park
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Earth Essence news portal sitemap